Original-Patent Rule Dooms Drug Injection Complaint
The Federal Circuit on Monday affirmed a lower court's decision to deny Antares Pharma Inc. an injunction in its patent infringement suit against Medac Pharma Inc., ruling that the reissue claims...To view the full article, register now.
Already a subscriber? Click here to view full article